About
TELA Bio, Inc. is a medical technology company based in Malvern, Pennsylvania, founded in 2012. The company focuses on designing and marketing tissue reinforcement materials for soft tissue reconstruction, particularly in reconstructive surgery. Its main product line, OviTex, includes solutions for hernia repair, abdominal wall reconstruction, and specialized products for plastic and reconstructive surgery. The OviTex products are engineered to enhance clinical outcomes by preserving patient anatomy and reducing reliance on permanent synthetic materials. TELA Bio markets its products through a direct sales force in the United States and has experienced significant growth, highlighted by its IPO on NASDAQ in 2019 and the acquisition of Novus Scientific AB in 2023, which expanded its offerings with the TIGR Matrix line. The company is dedicated to providing advanced biologic repair solutions to surgeons and healthcare providers, aiming to improve patient outcomes in various surgical procedures.
Technologies
Keywords
Company Information
-
Employees 210
-
Founded 2012
-
Annual Revenue $71217000
-
Total Funding $286248435
Location
1 Great Valley Pkwy, Malvern, Pennsylvania, United States, 19355